Joseph Alvarnas, MD: Understanding, in light of what you’ve all said, that cancer care is multidimensional and value is multidimensional, have value frameworks—such as those developed by the American ...
Concern about the rising costs of health care, particularly in specialty biopharmaceuticals, has led to the emergence of several value frameworks that are designed to help society, payers, and ...
To determine and compare the incremental clinical benefit (ICB) and costs of induction chemotherapy (IC) when added to concurrent chemoradiotherapy (CCRT), concurrent chemotherapy (CC) when added to ...
Value frameworks are one tool that can be used to inform the formulary decision-making process, but transparency in the development of these frameworks is important, said Susan A. Cantrell, RPh, CAE, ...
Changing the Natural History of Non–Small-Cell Lung Cancer Through Upfront Programmed Death Protein 1/Programmed Death-Ligand 1 Blockade Over a recent 15-year span, the price of new cancer therapies ...
ALEXANDRIA, Va., June 5, 2017 /PRNewswire-USNewswire/ -- To address escalating drug costs, health care payers increasingly are adopting benefit designs that aim to identify and pay for medications ...
In a world where pricing decisions are increasingly interconnected, a risk for healthcare leaders to consider is lagging evidence. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results